Common Contracts
9 similar Underwriting Agreement contracts by Bioheart, Inc., Archemix Corp., Cardiomems Inc, others
MONMOUTH REAL ESTATE INVESTMENT CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • March 9th, 2017 • Monmouth Real Estate Investment Corp • Real estate investment trusts • New York
Monmouth Real Estate Investment Corporation, a Maryland corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell an aggregate of 3,000,000 shares (the “Firm Shares”) of the Company’s 6.125% Series C Cumulative Redeemable Preferred Stock, $0.01 par value per share (the “Preferred Stock”), to the several underwriters named in Schedule I hereto (collectively, the “Underwriters”), for whom RBC Capital Markets, LLC, BMO Capital Markets Corp. and J.P. Morgan Securities LLC, are acting as representatives (collectively, the “Representatives”). The Company has also agreed to grant to the Underwriters an option to purchase up to an additional 450,000 shares of Preferred Stock (the “Option Shares”) solely to cover over-allotments, if any. The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares.” The Shares, when issued and delivered by the Company pursuant to this Agreement, will
Shares* XTERA COMMUNICATIONS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 26th, 2015 • Xtera Communications, Inc. • Telephone & telegraph apparatus • New York
Xtera Communications, Inc., a Delaware corporation (the “Company”), proposes to issue and sell shares (the “Firm Shares”) of the Company’s Common Stock, par value $0.001 (the “Common Stock”), to you (collectively, the “Underwriters” or “Representatives”). The Company has also agreed to grant to you and the other Underwriters an option (the “Option”) to purchase up to an additional shares of Common Stock, on the terms and for the purposes set forth in Section 1(b) (the “Option Shares”). The Firm Shares and the Option Shares are referred to collectively herein as the “Shares.”
Syndax Pharmaceuticals, Inc. Common Stock ($0.0001 Par Value) EQUITY UNDERWRITING AGREEMENTUnderwriting Agreement • May 16th, 2014 • Syndax Pharmaceuticals Inc • Pharmaceutical preparations • New York
Syndax Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representatives (the “Representatives”) an aggregate of shares (the “Firm Shares”) of the Company’s common stock, $0.0001 par value (the “Common Stock”). The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names on Schedule I hereto. The Company also proposes to sell at the Underwriters’ option an aggregate of up to additional shares of the Company’s Common Stock (the “Option Shares”) as set forth below.
WARREN RESOURCES, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 23rd, 2009 • Warren Resources Inc • Crude petroleum & natural gas • New York
Warren Resources, Inc., a Maryland corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell an aggregate of 11,775,000 shares (the “Securities”) of the Company’s common stock, $0.0001 par value per share (the “Common Stock”), to the several underwriters named in Schedule I (collectively, the “Underwriters”), for whom BMO Capital Markets Corp. and RBC Capital Markets Corporation are acting as representatives (the “Representatives”).
Shares Bioheart, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • December 21st, 2007 • Bioheart, Inc. • Services-commercial physical & biological research • New York
Merriman Curhan Ford & Co. Dawson James Securities, Inc. As Representatives of the Several Underwriters c/o Merriman Curhan Ford & Co. 600 California Street, 9th Floor San Francisco, California 94108
Shares Bioheart, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 16th, 2007 • Bioheart, Inc. • Services-commercial physical & biological research • New York
Merriman Curhan Ford & Co. Dawson James Securities, Inc. As Representatives of the Several Underwriters c/o Merriman Curhan Ford & Co. 600 California Street, 9th Floor San Francisco, California 94108
Archemix Corp. Common Stock UNDERWRITING AGREEMENT dated [ ], 2007 Banc of America Securities LLC Bear, Stearns & Co. Inc.Underwriting Agreement • October 23rd, 2007 • Archemix Corp. • Pharmaceutical preparations • New York
Introductory. Archemix Corp., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of [___] shares (the “Firm Shares”) of its Common Stock, par value $.001 per share (the “Common Stock”). In addition, the Company has granted to the Underwriters an option to purchase up to an additional [___] shares (the “Optional Shares”) of Common Stock, as provided in Section 2. The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the “Shares”. Banc of America Securities LLC (“BAS”) and Bear, Stearns & Co. Inc. (“Bear Stearns”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Shares.
Shares Bioheart, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • September 6th, 2007 • Bioheart, Inc. • Services-commercial physical & biological research • New York
Merriman Curhan Ford & Co. Dawson James Securities, Inc. As Representatives of the Several Underwriters 3 Times Square New York, New York 10036
CardioMEMS, Inc. Common Stock UNDERWRITING AGREEMENT dated [ ] Banc of America Securities LLC CIBC World Markets Corp. Jefferies & Company, Inc. Pacific Growth Equities LLCUnderwriting Agreement • April 19th, 2007 • Cardiomems Inc • Surgical & medical instruments & apparatus • New York
